Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Revenue

Syndax Pharmaceuticals had revenue of $37.96M in the quarter ending June 30, 2025, with 984.51% growth. This brings the company's revenue in the last twelve months to $77.93M, up 2,126.66% year-over-year. In the year 2024, Syndax Pharmaceuticals had annual revenue of $23.68M.

• Revenue (ttm): $77.93M
• Revenue Growth: +2,126.66%
• P/S Ratio: 14.86
• Revenue / Employee: $288,641
• Employees: 270
• Market Cap: 1.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	23.68M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	139.71M	138.19M	9,109.56%
Dec 31, 2020	1.52M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.